Methods for the cryopreservation of cells

Patent metadata

Field	Value
Publication number	US-9538745-B2
Application number	US-22630007-A
Country	US
Kind code	B2
Filing date	Apr 12, 2007
Priority date	Apr 14, 2006
Publication date	Jan 10, 2017
Grant date	Jan 10, 2017

Abstract

The present invention features novel methods for the cryopreservation of mammalian cell that combine the advantages of the slow-freezing and vitrification approaches while avoiding their shortcomings. Generally, the methods include the use of a capillary tube made of a thermally conductive wall material and a thin wall such that the ratio of the thermal conductivity of the wall material to the wall thickness is at least 1,000-500,000. The solution is then exposed to temperatures equal to or less than −80° C. and the vitrification solution containing the mammalian cells is cooled at a rate equal to or greater than 30,000-100,000,000° C./minute. The exposure of the capillary tube with a thermally conductive and thin wall allows for vitrification of the solution in the absence of ice formation. Cryoprotectants can also be added to the vitrification solution to further prevent ice formation.

First claim

What is claimed is:

1. A method for cryopreserving a mammalian cell, the method comprising:
(a) suspending said cell in a vitrification solution comprising one or more cryoprotective agents, wherein a concentration of the combination of all cryoprotective agents in said vitrification solution is less than or equal to 4 M;
(b) placing said cell in said vitrification solution in a microcapillary tube, wherein said microcapillary tube has a wall made of a material having a thermal conductivity of at least 0.2 W m −1 K −1 ; and
(c) cooling said cell in said vitrification solution in said microcapillary tube to a temperature less than or equal to a glass transition temperature of said vitrification solution at a rate greater than 200,000° C./min, wherein said cooling causes vitrification of said cell.

2. The method of claim 1 , wherein said cell is an oocyte, a stem cell, an embryo, or a zygote.

3. The method of claim 2 , wherein said cell is an oocyte, an embryo, or a zygote.

4. The method of claim 2 , wherein said cell is a stem cell.

5. The method of claim 1 , wherein said microcapillary tube comprises a wall having a thickness of 10 to 20 μm.

6. The method of claim 1 , wherein said microcapillary tube comprises an inner diameter of about 80 to 180 μm.

7. The method of claim 1 , wherein said microcapillary tube has a wall made of a material having a thermal conductivity of at least 5 W m −1 K −1 .

8. The method of claim 1 , wherein said microcapillary tube has a wall made of a material selected from the group consisting of plastic, glass, quartz, stainless steel, sapphire, silver, copper, diamond, gold, titanium, palladium, and platinum.

9. The method of claim 8 , wherein said material is quartz.

10. The method of claim 1 , wherein said cell in said vitrification solution is cooled at a rate equal to or greater than 350,000° C./min.

11. The method of claim 10 , wherein said cell in said vitrification solution is cooled at a rate equal to or greater than 1,000,000° C./min.

12. The method of claim 1 , wherein said at least one cryoprotective agent is selected from the group consisting of a sugar, glycerol, ethylene glycol, 1,2-propanediol, and DMSO.

13. The method of claim 1 , wherein said concentration of the combination of all cryoprotective agents in said vitrification solution less than or equal to 3 M.

14. The method of claim 13 , wherein said concentration of the combination of all cryoprotective agents in the vitrification solution is less than or equal to 2 M.

15. The method of claim 13 , wherein said concentration of the combination of all cryoprotective agents in said vitrification solution is less than or equal to 1 M.

16. The method of claim 13 , wherein said concentration of the combination of all cryoprotective agents in said vitrification solution is less than or equal to 0.5 M.

17. The method of claim 13 , wherein said concentration of the combination of all cryoprotective agents in said vitrification solution is less than or equal to 0.3 M.

18. The method of claim 1 , wherein said vitrification solution comprises at least one nanoparticle or microparticle.

19. The method of claim 18 , wherein said nanoparticle or microparticle comprises carbon or a noble metal.

20. The method of claim 18 , wherein said nanoparticle or microparticle is selected from the group consisting of gold, silver, titanium, palladium, platinum, and copper.

21. The method of claim 1 , wherein said vitrification solution comprises one or more polymers or peptides, or both, that inhibit ice nucleation in said vitrification solution.

22. The method of claim 21 , wherein said polymer or peptide is selected from the group consisting of polyvinyl alcohol, polyglycerol, and antifreeze proteins.

23. The method of claim 1 , wherein said cell in said vitrification solution is emulsified into a droplet of vitrification solution surrounded by an immiscible biocompatible fluid.

24. The method of claim 23 , wherein said immiscible biocompatible fluid comprises an oil.

25. The method of claim 1 , further comprising shaking the tube at a frequency of at least 1.0-100 Hz after step (b).

26. The method of claim 1 , wherein a wall of said microcapillary tube has a ratio of wall material thermal conductivity (watts per meter kelvin) to wall thickness (meters) of at least 1,000 watts per meter squared Kelvin (Wm −2 K −1 ).

27. The method of claim 26 , wherein said microcapillary tube has a ratio of wall material thermal conductivity to wall thickness of at least 500,000 Wm −2 K −1 .

28. The method of claim 26 , wherein said microcapillary tube has a ratio of wall material thermal conductivity to wall thickness of at least 5,000 Wm −2 K −1 .

29. The method of claim 26 , wherein said microcapillary tube has a ratio of wall material thermal conductivity to wall thickness of at least 10,000 Wm −2 K −1 .

30. The method of claim 26 , wherein said microcapillary tube has a ratio of wall material thermal conductivity to wall thickness of at least 100,000 Wm −2 K −1 .

31. The method of claim 1 , wherein said cell is cooled by plunging at least a portion of the microcapillary tube from room temperature into slush nitrogen.

32. The method of claim 1 , wherein said concentration of the combination of all cryoprotective agents in said vitrification solution is less than or equal to 2 M.

33. The method of claim 1 , wherein the one or more cryoprotective agents comprise 1,2-propanediol (PROH) or propylene glycol at a concentration of 1 M to 2 M and a sugar at a concentration of 0.2 M to 1 M.

34. The method of claim 33 , wherein the sugar comprises one or more of sucrose, trehalose, raffinose, stachyose, and dextran.

35. The method of claim 34 , wherein the cryoprotective agents comprise 1.5 M to 2.0 M PROH and 0.3 M to 0.5 M trehalose.

Assignees

• He Xiaoming
• Toth Thomas L
• Toner Mehmet
• Edd Jon
• Massachusetts Gen Hospital

Inventors

• He Xiaoming
• Toth Thomas L
• Toner Mehmet
• Edd Jon

Classifications

• A01N1/0268

  Human Necessities · mapped topic

• A01N1/0278

  Human Necessities · mapped topic

• A01N1/02 Primary

  Human Necessities · mapped topic

• A01N1/0221

  Human Necessities · mapped topic

• A01N1/147

  Carriers for immersion in cryogenic fluid for slow freezing or vitrification · CPC title